| Targeted therapy for patients with BRAF-mutant lung cancer results from the European EURAF cohort O Gautschi, J Milia, B Cabarrou, MV Bluthgen, B Besse, EF Smit, J Wolf, ... Journal of Thoracic Oncology 10 (10), 1451-1457, 2015 | 198 | 2015 |
| Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology B Cabarrou, P Sfumato, L Mourey, E Leconte, L Balardy, A Martinez, ... European Journal of Cancer 103, 120-126, 2018 | 37 | 2018 |
| VOTRAGE study: Phase I dose-escalation study of pazopanib in unfit older patients. J Geriatr Oncol S1879-4068 (21) 00015-1 L Mourey, F Le Louedec, A Ravaud, MN Paludetto, L Digue, ... | 31 | 2021 |
| Impact of micronutrient deficiency & malnutrition in systemic sclerosis: Cohort study and literature review R Dupont, M Longué, A Galinier, CC Frais, C Ingueneau, L Astudillo, ... Autoimmunity reviews 17 (11), 1081-1089, 2018 | 28 | 2018 |
| Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study JB Beauval, B Peyronnet, T Benoit, B Cabarrou, T Seisen, M Roumiguié, ... World journal of urology 36, 897-904, 2018 | 27 | 2018 |
| Impact of a comprehensive geriatric assessment on decision‐making in older patients with hematological malignancies M Garric, S Sourdet, B Cabarrou, Z Steinmeyer, M Gauthier, L Ysebaert, ... European Journal of Haematology 106 (5), 616-626, 2021 | 18 | 2021 |
| A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer MA Angeles, A Rychlik, B Cabarrou, E Spagnolo, F Guyon, ... Gynecologic Oncology 158 (3), 614-621, 2020 | 17 | 2020 |
| Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey C Syrykh, C Chaouat, E Poullot, N Amara, V Fataccioli, M Parrens, ... Blood, The Journal of the American Society of Hematology 140 (24), 2573-2583, 2022 | 16 | 2022 |
| Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy JB Beauval, G Ploussard, B Cabarrou, M Roumiguié, A Ouzzane, J Gas, ... World Journal of Urology 35, 1191-1197, 2017 | 16 | 2017 |
| Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study V Tostivint, G Verhoest, B Cabarrou, J Gas, P Coloby, J Zgheib, ... World journal of urology 39, 2525-2530, 2021 | 15 | 2021 |
| How to report toxicity associated with targeted therapies? B Cabarrou, JM Boher, E Bogart, E Tresch-Bruneel, N Penel, A Ravaud, ... Annals of oncology 27 (8), 1633-1638, 2016 | 15 | 2016 |
| Risk factors for pharyngocutaneous fistula after total pharyngolaryngectomy E Lemaire, P Schultz, S Vergez, C Debry, J Sarini, B Vairel, ... Ear, Nose & Throat Journal 100 (5_suppl), 746S-752S, 2021 | 12 | 2021 |
| Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS C Syrykh, P Gorez, S Péricart, D Grand, F Escudié, B Cabarrou, L Obéric, ... Blood Advances 5 (22), 4590-4593, 2021 | 11 | 2021 |
| Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer MA Angeles, G Ferron, B Cabarrou, G Balague, C Martínez-Gómez, ... European Journal of Surgical Oncology 45 (8), 1410-1416, 2019 | 11 | 2019 |
| Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine P Bories, N Prade, S Lagarde, B Cabarrou, L Largeaud, ... PLoS One 15 (10), e0238795, 2020 | 10 | 2020 |
| External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients JB Beauval, B Cabarrou, G Gandaglia, PM Patard, A Ouzzane, ... The Prostate 77 (8), 928-933, 2017 | 10 | 2017 |
| Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer S Betrian, MA Angeles, AG Moreno, B Cabarrou, M Deslandres, G Ferron, ... International Journal of Gynecologic Cancer 32 (8), 2022 | 9 | 2022 |
| Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for … MA Angeles, E Mallet, P Rouanet, B Cabarrou, P Méeus, E Lambaudie, ... International Journal of Gynecologic Cancer 30 (2), 2020 | 9 | 2020 |
| The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patients M Longué, B Cabarrou, J Wallet, T Brodowicz, H Roché, JM Boher, ... Annals of Oncology 29 (7), 1588-1593, 2018 | 8 | 2018 |
| Hypofractionnated stereotactic radiotherapy and anti-PDL1 durvalumab combination in recurrent glioblastoma: Results of the phase I part of the phase I/II STERIMGLI trial. D Pouessel, A Mervoyer, D Larrieu-Ciron, B Cabarrou, J Attal, M Robert, ... Journal of Clinical Oncology 36 (15_suppl), 2046-2046, 2018 | 8 | 2018 |
